Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

ER Lepper; SD Baker; M Permenter; N Ries; Ron van Schaik; PW Schenk; DK Price; D Ahn; NF Smith; G Cusatis; RG Ingersoll; SE Bates; RHJ Mathijssen; Jaap Verweij; WD Figg; A Sparreboom

doi:10.1158/1078-0432.CCR-05-0520

Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

ER Lepper, SD Baker, M Permenter, N Ries, Ron van Schaik, PW Schenk, DK Price, D Ahn, NF Smith, G Cusatis, RG Ingersoll, SE Bates, RHJ Mathijssen, Jaap Verweij, WD Figg, A Sparreboom

Research output: Contribution to journal › Article › Academic › peer-review

65 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	7398-7404
Number of pages	7
Journal	Clinical Cancer Research
Volume	11
Issue number	20
DOIs	https://doi.org/10.1158/1078-0432.CCR-05-0520
Publication status	Published - 2005

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1158/1078-0432.CCR-05-0520

http://hdl.handle.net/1765/59948

Cite this

Lepper, ER., Baker, SD., Permenter, M., Ries, N., van Schaik, R., Schenk, PW., Price, DK., Ahn, D., Smith, NF., Cusatis, G., Ingersoll, RG., Bates, SE., Mathijssen, RHJ., Verweij, J., Figg, WD., & Sparreboom, A. (2005). Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients. Clinical Cancer Research, 11(20), 7398-7404. https://doi.org/10.1158/1078-0432.CCR-05-0520

Lepper, ER ; Baker, SD ; Permenter, M ; Ries, N ; van Schaik, Ron ; Schenk, PW ; Price, DK ; Ahn, D ; Smith, NF ; Cusatis, G ; Ingersoll, RG ; Bates, SE ; Mathijssen, RHJ ; Verweij, Jaap ; Figg, WD ; Sparreboom, A. / Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients. In: Clinical Cancer Research. 2005 ; Vol. 11, No. 20. pp. 7398-7404.

@article{2063ea869e494aa2bfba638fd654838c,

title = "Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients",

author = "ER Lepper and SD Baker and M Permenter and N Ries and {van Schaik}, Ron and PW Schenk and DK Price and D Ahn and NF Smith and G Cusatis and RG Ingersoll and SE Bates and RHJ Mathijssen and Jaap Verweij and WD Figg and A Sparreboom",

year = "2005",

doi = "10.1158/1078-0432.CCR-05-0520",

language = "Undefined/Unknown",

volume = "11",

pages = "7398--7404",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

number = "20",

}

Lepper, ER, Baker, SD, Permenter, M, Ries, N, van Schaik, R, Schenk, PW, Price, DK, Ahn, D, Smith, NF, Cusatis, G, Ingersoll, RG, Bates, SE, Mathijssen, RHJ, Verweij, J, Figg, WD & Sparreboom, A 2005, 'Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients', Clinical Cancer Research, vol. 11, no. 20, pp. 7398-7404. https://doi.org/10.1158/1078-0432.CCR-05-0520

Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients. / Lepper, ER; Baker, SD; Permenter, M; Ries, N; van Schaik, Ron; Schenk, PW; Price, DK; Ahn, D; Smith, NF; Cusatis, G; Ingersoll, RG; Bates, SE; Mathijssen, RHJ; Verweij, Jaap; Figg, WD; Sparreboom, A.

In: Clinical Cancer Research, Vol. 11, No. 20, 2005, p. 7398-7404.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Effect of common CYP3A4 and CYP3A5 variants on the pharmacokinetics of the cytochrome P450 3A phenotyping probe midazolam in cancer patients

AU - Lepper, ER

AU - Baker, SD

AU - Permenter, M

AU - Ries, N

AU - van Schaik, Ron

AU - Schenk, PW

AU - Price, DK

AU - Ahn, D

AU - Smith, NF

AU - Cusatis, G

AU - Ingersoll, RG

AU - Bates, SE

AU - Mathijssen, RHJ

AU - Verweij, Jaap

AU - Figg, WD

AU - Sparreboom, A

PY - 2005

Y1 - 2005

U2 - 10.1158/1078-0432.CCR-05-0520

DO - 10.1158/1078-0432.CCR-05-0520

M3 - Article

VL - 11

SP - 7398

EP - 7404

JO - Clinical Cancer Research

JF - Clinical Cancer Research

SN - 1078-0432

IS - 20

ER -